Literature DB >> 1901830

The effect of class II gene transfection on the tumourigenicity of the H-2K-negative mouse leukaemia cell line K36.16.

R F James1, S Edwards, K M Hui, P D Bassett, F Grosveld.   

Abstract

There is much evidence to suggest that potentially immunogenic tumour cells can escape cytolytic immune destruction by loss of class I antigen expression. Many tumours are allele-specific class I negative and, in murine systems, reconstitution of class I expression by gene transfection leads to an increase in tumour immunogenicity. In many systems where mice have rejected class I transfected tumour cells they are also immune to a subsequent challenge with the untransfected parent tumour. In this study we have examined the effect of stable class II antigen expression (induced by gene transfection) on a class I loss mutant (H-2Kk negative) murine cell line, K36.16. We show that H-2Ek expression is more effective at increasing tumour immunogenicity than the reconstitution of H-2Kk expression in these cells. This suggests that the induction of class II antigen expression on tumour cells may provide an effective way of enhancing tumour-specific immune responses in vivo.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1901830      PMCID: PMC1384486     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  19 in total

Review 1.  Genes controlling the metastatic phenotype.

Authors:  M Feldman; L Eisenbach
Journal:  Cancer Surv       Date:  1988

Review 2.  Variation in HLA expression on tumors: an escape from immune response.

Authors:  M E Smith; J G Bodmer; A P Kelly; J Trowsdale; S C Kirkland; W F Bodmer
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1989

3.  Cell-mediated immune response to syngeneic UV-induced tumors. III. Requirement for an Ia+ macrophage in the in vitro differentiation of cytotoxic T lymphocytes.

Authors:  J G Woodward; P A Fernandez; R A Daynes
Journal:  J Immunol       Date:  1979-04       Impact factor: 5.422

4.  Selective loss of HLA-A,B,C locus products in colorectal adenocarcinoma.

Authors:  M E Smith; W F Bodmer; J G Bodmer
Journal:  Lancet       Date:  1988-04-09       Impact factor: 79.321

Review 5.  The influence of major histocompatibility complex class I antigens on tumor growth and metastasis.

Authors:  G J Hämmerling; D Klar; W Pülm; F Momburg; G Moldenhauer
Journal:  Biochim Biophys Acta       Date:  1987-11-25

6.  Tumour prevention and rejection with recombinant vaccinia.

Authors:  R Lathe; M P Kieny; P Gerlinger; P Clertant; I Guizani; F Cuzin; P Chambon
Journal:  Nature       Date:  1987 Apr 30-May 6       Impact factor: 49.962

7.  Xenogenization of a mouse lung carcinoma (3LL) by transfection with an allogeneic class I major histocompatibility complex gene (H-2Ld).

Authors:  T Itaya; S Yamagiwa; F Okada; T Oikawa; N Kuzumaki; N Takeichi; M Hosokawa; H Kobayashi
Journal:  Cancer Res       Date:  1987-06-15       Impact factor: 12.701

8.  HLA-DR expression is associated with excellent prognosis in squamous cell carcinoma of the larynx.

Authors:  F Esteban; F Ruiz-Cabello; A Concha; M Pérez-Ayala; J A Sánchez-Rozas; F Garrido
Journal:  Clin Exp Metastasis       Date:  1990 Jul-Aug       Impact factor: 5.150

9.  Rejection of transplantable AKR leukaemia cells following MHC DNA-mediated cell transformation.

Authors:  K Hui; F Grosveld; H Festenstein
Journal:  Nature       Date:  1984 Oct 25-31       Impact factor: 49.962

10.  Tracts of high or low sequence divergence in the mouse major histocompatibility complex.

Authors:  M Steinmetz; M Malissen; L Hood; A Orn; R A Maki; G R Dastoornikoo; D Stephan; E Gibb; R Romaniuk
Journal:  EMBO J       Date:  1984-12-01       Impact factor: 11.598

View more
  11 in total

1.  Modulation of MHC antigen expression by viruses and oncogenes.

Authors:  D J Maudsley; J D Pound
Journal:  Immunol Today       Date:  1991-12

2.  Major histocompatibility complex class II-transfected tumor cells present endogenous antigen and are potent inducers of tumor-specific immunity.

Authors:  T D Armstrong; V K Clements; B K Martin; J P Ting; S Ostrand-Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-24       Impact factor: 11.205

3.  The loss of class II MHC antigen expression by ras-transformed murine fibroblasts passaged as tumours correlates with increased tumorigenicity but is not mediated by T cells.

Authors:  A G Morris; R L Darley; W J Bateman
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

4.  An immunodominant SSX-2-derived epitope recognized by CD4+ T cells in association with HLA-DR.

Authors:  Maha Ayyoub; Charles S Hesdorffer; Monica Montes; Andrea Merlo; Daniel Speiser; Donata Rimoldi; Jean-Charles Cerottini; Gerd Ritter; Matthew Scanlan; Lloyd J Old; Danila Valmori
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

Review 5.  Genes, dreams, and cancer.

Authors:  K Sikora
Journal:  BMJ       Date:  1994-05-07

6.  The immunogenicity of L1210 lymphoma clones correlates with their ability to function as antigen-presenting cells.

Authors:  Kelly A Cycon; James L Clements; Renae Holtz; Hiroshi Fuji; Shawn P Murphy
Journal:  Immunology       Date:  2009-01-12       Impact factor: 7.397

7.  Melanoma cells present a MAGE-3 epitope to CD4(+) cytotoxic T cells in association with histocompatibility leukocyte antigen DR11.

Authors:  S Manici; T Sturniolo; M A Imro; J Hammer; F Sinigaglia; C Noppen; G Spagnoli; B Mazzi; M Bellone; P Dellabona; M P Protti
Journal:  J Exp Med       Date:  1999-03-01       Impact factor: 14.307

8.  Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors.

Authors:  F Ossendorp; E Mengedé; M Camps; R Filius; C J Melief
Journal:  J Exp Med       Date:  1998-03-02       Impact factor: 14.307

9.  Strong HLA-DR expression in large bowel carcinomas is associated with good prognosis.

Authors:  S N Andersen; T O Rognum; E Lund; G I Meling; S Hauge
Journal:  Br J Cancer       Date:  1993-07       Impact factor: 7.640

10.  HLA-DR antigen expression in colorectal carcinomas: influence of expression by IFN-gamma in situ and its association with tumour progression.

Authors:  K Matsushita; T Takenouchi; S Kobayashi; H Hayashi; K Okuyama; T Ochiai; A Mikata; K Isono
Journal:  Br J Cancer       Date:  1996-03       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.